Lower Rr

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

A Hastillo

Virginia Commonwealth University

Lee Hm

Central Taiwan University of Science and Technology

Hess Ml

Virginia Commonwealth University

Shumway Ne

Stanford University

S Szentpetery

Virginia Commonwealth University Medical Center

G Méndez-Picón

Henrico Doctors' Hospital

Hurley Ej

University of California, Davis

Szabolcs Szentpetery

Hunter Holmes McGuire VA Medical Center

Thomas Ft

University of Alabama at Birmingham

Goldman Mh

Englewood Hospital and Medical Center

Cooperative Institutions

Virginia Commonwealth University Medical Center

Virginia Commonwealth University

Hunter Holmes McGuire VA Medical Center

East Carolina University

University of Richmond

Massachusetts General Hospital

Harvard University

University of Alabama at Birmingham

National Institutes of Health

Stanford University

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Monitoring of cytotoxic T cell function in cardiac transplant recipients: the immediate posttransplant period.

PubMed (1984)

Cohen Dj T Mohanakumar Cheryl Johns Goldman Mh Timothy C. Wolfgang

Source

Cite

Citations (0)

Value of immunologic monitoring studies of human E, EA, and EAC rosetting lymphocyte subpopulations in renal and cardiac transplantation.

PubMed (1981)

F Thomas Lee Hm Lower Rr Thomas Jm

Immunosuppression

Value (mathematics)

Source

Cite

Citations (3)

Management and long-term followup of outpatient care in the cardiac transplant recipient.

PubMed (1990)

Thompson Ja S Rider-Katz Hess Ml Alain Heroux A Hastillo

Successful long-term management of the cardiac transplant patient requires the concerted effort of the patient, the cardiac transplant team, and the primary care physician. The long-term management of these patients will continue to evolve as new immunosuppressive agents are used and new methods of surveillance for rejection are found. The long-term management is indeed one of the most exciting parts of the care of the transplant patient, especially when all those involved can watch the patient enter into a normal lifestyle.

Source

Cite

Citations (0)

Histopathology of orthotopic canine cardiac homografts and its clinical correlation.

PubMed (1969)

Kosek Jc Hurley Ej Sewell Dh Lower Rr

Histopathology

Source

Cite

Citations (14)

Plasma renin responses to hemorrhage after cardiac autotransplantation

American Journal of Physiology-Legacy Content (1971)

M D Thames Zubair-ul-Hassan Brackett Nc Lower Rr HA Kontos

Plasma renin activity

10.1152/ajplegacy.1971.221.4.1115

Cite

Citations (30)

Role of DL-A system of canine histocompatibility in cardiac transplantation.

PubMed (1971)

Boyd Ad Rapaport Ft Ferrebee Jw Cannon Fd J Dausset

Histocompatibility

Histocompatibility Testing

Source

Cite

Citations (6)

Cardiac transplantation--1980: The Medical College of Virginia program.

PubMed (1980)

A Hastillo Hess Ml Richardson Dw Lower Rr

Within the last three years, advances in the fields of cardiac surgery and immunology have established the value of cardiac transplantation for patients with irreversible myopathic disease. Long-distance donor procurement has increased the availability of the donor pool and made possible a more critical selection of donor hearts. The development of antithymocyte globulin and the concept of individual immune monitoring has decreased the incidence of acute rejection and the dosage of prednisone and azathioprine necessary to achieve optimal graft protection. These advances are reflected in the survival statistics. Since 1977, the three-month mortality rate has decreased to 40%, as compared to 77% from 1968 to 1976. Ptatients who are discharged from the hospital are currently demonstrating an 88% one-year survival rate and are functional class I-II status. We conclude that in properly selected patients, cardiac transplantation is a viable option for end-stage cardiomyopathic disease.

Source

Cite

Citations (6)

Beta 2 microglobulin and the diagnosis of cardiac transplant rejection.

PubMed (1983)

Goldman Mh Richard W. Lippman Douglas M. Landwehr Szabolcs Szentpetery Timothy C. Wolfgang

Dans 75% des cas, les episodes de rejet apres transplantation cardiaque s'accompagnent d'une augmentation de la beta 2 microglobuline serique (et urinaire). Cette augmentation peut preceder les manifestations cliniques du rejet (revue de 20 episodes de rejet chez 10 malades)

Beta-2 microglobulin

BETA (programming language)

Source

Cite

Citations (6)

Increase in transferrin receptors as a marker for rejection and infection in human cardiac transplantation.

PubMed (1987)

Kiyotaka Hoshinaga T. Mohanakumar Wood Nl S Szentpetery Lower Rr

Transferrin receptor

Source

Cite

Citations (2)